Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,884 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
Kim YJ, Kim DW, Lee S, Min CK, Goh HG, Kim SH, Lee JY, Kim YL, Kim HJ, Kim HJ, Lee JW, Kim TG, Min WS, Kim CC. Kim YJ, et al. Among authors: kim cc, kim hj, kim dw, kim yl, kim tg, kim sh. Biol Blood Marrow Transplant. 2004 Oct;10(10):718-25. doi: 10.1016/j.bbmt.2004.06.033. Biol Blood Marrow Transplant. 2004. PMID: 15389438 Free article. Clinical Trial.
The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S, Kim YJ, Min CK, Kim HJ, Eom KS, Kim DW, Lee JW, Min WS, Kim CC. Lee S, et al. Among authors: kim cc, kim yj, kim hj, kim dw. Blood. 2005 May 1;105(9):3449-57. doi: 10.1182/blood-2004-09-3785. Epub 2005 Jan 18. Blood. 2005. PMID: 15657178 Free article. Clinical Trial.
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome.
Cho BS, Kim YJ, Cho SG, Kim SY, Eom KS, Kim HJ, Lee S, Min CK, Kim DW, Lee JW, Min WS, Kim CC. Cho BS, et al. Among authors: kim cc, kim yj, kim hj, kim dw, kim sy. Int J Hematol. 2007 Jun;85(5):446-55. doi: 10.1532/IJH97.A30616. Int J Hematol. 2007. PMID: 17562624 Clinical Trial.
21,884 results
You have reached the last available page of results. Please see the User Guide for more information.